Tokyo, Japan

Toshiya Noguchi


 

Average Co-Inventor Count = 9.1

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Tokyo, JP (2012 - 2013)
  • Toshima-ku, JP (2013)

Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Toshiya Noguchi: Innovator in Antibacterial Compounds

Introduction

Toshiya Noguchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of 5 patents, his work has been instrumental in addressing the challenges posed by drug-resistant bacteria.

Latest Patents

Among his latest patents, Noguchi has developed quinolinones and quinoxalinones as antibacterial compositions. These nitrogen-containing heterocyclic compounds exhibit potent antibacterial activity and high safety profiles. They are particularly useful against gram-positive bacteria, gram-negative bacteria, and drug-resistant strains. Another notable patent involves a heterocyclic compound or its salt, which is represented by a specific general formula. This compound is designed to serve as an effective antibacterial agent, showcasing the innovative nature of Noguchi's research.

Career Highlights

Throughout his career, Toshiya Noguchi has worked with reputable companies such as Toyama Chemical Co., Ltd. and Taisho Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Noguchi has collaborated with notable colleagues, including Taro Kiyoto and Fumihito Ushiyama. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Toshiya Noguchi's contributions to the field of antibacterial agents highlight his innovative spirit and dedication to addressing critical health challenges. His work continues to influence the pharmaceutical industry and improve treatment options for bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…